ArticleJournal of thoracic disease2025
Outpatient opioid use after minimally invasive surgery for lung cancer: a Surveillance, Epidemiology, and End Results-Medicare cohort study.
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Opioids are commonly used for postoperative pain after lung resection. It is unclear whether opioid use differs between minimally invasive thoracoscopic approaches. We compared opioid use following robotic-assisted surgery (RAS) and video-assisted thoracoscopic surgery (VATS). Methods: The Surveillance, Epidemiology, and End Results-Medicare claims database was queried for patients who underwent resection of non-small cell lung cancer (NSCLC) between January 2016 and July 2020. Outcomes included any opioid, abuse-potential (schedule II/III), and high-dose (≥50 morphine milligram equivalents/day) opioid fill, assessed across immediate (0-42 days), short-term (43-90 days), and long-term (91-180 days) periods. Inverse-probability of treatment weighted logistic regression was used to compare RAS and VATS. Results: A total of 4,243 eligible patients (1,157 RAS Conclusions: RAS was associated with reduced short-term opioid use compared to VATS after NSCLC resection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.